Mayo Clinic said it took down the webpage last month to “make it clear that hydroxychloroquine should not be used to treat COVID-19 patients.”
Peter Navarro, who directed the Office of Trade and Manufacturing Policy under President Donald Trump, cited the site on X, formerly known as Twitter, on Sept. 24: “From Mayo Clinic website grudging admission of glaring truth: ‘Hydroxychloroquine may be used to treat coronavirus (COVID-19) in certain hospitalized patients.'” Mayo removed the webpage two days later.
Mayo Clinic made its hydroxychloroquine page live again in October, deleting all references to COVID-19.
“Hydroxychloroquine is not part of Mayo Clinic’s prescribed treatment algorithms for COVID-19,” a health system spokesperson emailed Becker’s. “Mayo Clinic does not endorse the use of hydroxychloroquine for treating COVID-19 patients. We became aware that inaccurate information about hydroxychloroquine was included on one of our webpages. We removed the webpage and updated it to make it clear that hydroxychloroquine should not be used to treat COVID-19 patients.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
